Segmental Vitiligo Following Acitretin Treatment for Infantile Generalized Pustular Psoriasis Resulting in Repigmentation under Secukinumab Therapy
Yijun Yang,Qianyue Xu,Zhen Zhang,Zhirong Yao
DOI: https://doi.org/10.1111/dth.15305
2022-01-01
Dermatologic Therapy
Abstract:Dermatologic TherapyVolume 35, Issue 4 e15305 LETTER Segmental vitiligo following acitretin treatment for infantile generalized pustular psoriasis resulting in repigmentation under secukinumab therapy Yijun Yang, Yijun Yang orcid.org/0000-0003-4974-8012 Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorQianyue Xu, Qianyue Xu orcid.org/0000-0002-9431-411X Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorZhen Zhang, Zhen Zhang orcid.org/0000-0003-1344-9272 Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorZhirong Yao, Corresponding Author Zhirong Yao [email protected] orcid.org/0000-0001-5338-6304 Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China Correspondence Zhirong Yao, Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, 1665 Kongjiang Road, Yangpu District, Shanghai 200092, China. Email: [email protected]Search for more papers by this author Yijun Yang, Yijun Yang orcid.org/0000-0003-4974-8012 Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorQianyue Xu, Qianyue Xu orcid.org/0000-0002-9431-411X Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorZhen Zhang, Zhen Zhang orcid.org/0000-0003-1344-9272 Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaSearch for more papers by this authorZhirong Yao, Corresponding Author Zhirong Yao [email protected] orcid.org/0000-0001-5338-6304 Department of Dermatology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China Institute of Dermatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China Correspondence Zhirong Yao, Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, 1665 Kongjiang Road, Yangpu District, Shanghai 200092, China. Email: [email protected]Search for more papers by this author First published: 07 January 2022 https://doi.org/10.1111/dth.15305Citations: 1 Funding information: This study was supported by grants from the National Natural Science Foundation of China (81630083, 81874252). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Namba C, Murakami M, Hanakawa Y, et al. Infantile generalized pustular psoriasis: successful disease control with intermittent etretinate. J Dermatol. 2014; 41(5): 403-406. 2Hussain S, Berki DM, Choon SE, et al. IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis. J Allergy Clin Immunol. 2015; 135(4): 1067-1070 e1069. 3Böhner A, Roenneberg S, Eyerich K, Eberlein B, Biedermann T. Acute generalized pustular psoriasis treated with the IL-17A antibody Secukinumab. JAMA Dermatol. 2016; 152(4): 482-484. 4Mery-Bossard L, Bagny K, Chaby G, et al. New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases. J Eur Acad Dermatol Venereol JEADV. 2017; 31(1): 181-186. 5Goodwin RG, Finlay AY, Anstey AV. Vitiligo following narrow-band TL-01 phototherapy for psoriasis. Br J Dermatol. 2001; 144(6): 1264-1266. 6Halcin C, Hann SK, Kauh YC. Vitiligo following the resolution of psoriatic plaques during PUVA therapy. Int J Dermatol. 1997; 36(7): 534-536. 7Speeckaert R, Mylle S, van Geel N. IL-17A is not a treatment target in progressive vitiligo. Pigment Cell Melanoma Res. 2019; 32(6): 842-847. 8Palazzo G. Resolution of post-adalimumab vitiligo with secukinumab in a patient with psoriasis vulgaris. Oxf Med Case Reports. 2020; 2020(1):omz134. 9Liu LY, Strassner JP, Refat MA, Harris JE, King BA. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure. J Am Acad Dermatol. 2017; 77(4): 675-682 e671. Citing Literature Volume35, Issue4April 2022e15305 ReferencesRelatedInformation